Kazunori Nishizaki Selected Research

Maxillary Sinus Neoplasms

10/2020	Pathological evaluation of radiotherapy and concomitant intraarterial cisplatin for maxillary sinus cancer.
11/2019	Dose distribution of intensity-modulated proton therapy with and without a multi-leaf collimator for the treatment of maxillary sinus cancer: a comparative effectiveness study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazunori Nishizaki Research Topics

Disease

18	Inflammation (Inflammations) 03/2020 - 05/2006
17	Rhinosinusitis 01/2021 - 01/2009
16	Hearing Loss (Hearing Impairment) 01/2021 - 02/2002
14	Neoplasms (Cancer) 07/2021 - 06/2002
13	Eosinophilia 04/2019 - 01/2004
12	Nasal Polyps (Nasal Polyp) 01/2021 - 04/2009
8	Allergic Rhinitis 04/2014 - 01/2004
7	Otitis Media with Effusion 01/2020 - 05/2003
7	Sensorineural Hearing Loss 01/2018 - 12/2010
6	Seasonal Allergic Rhinitis (Hay Fever) 06/2022 - 06/2012
6	Noise-Induced Hearing Loss (Acoustic Trauma) 04/2021 - 01/2013
6	Otitis Media 01/2020 - 05/2013
5	Deafness (Deaf Mutism) 01/2017 - 02/2002
5	IGA Glomerulonephritis (IGA Nephropathy) 01/2011 - 12/2004
4	Head and Neck Neoplasms (Head and Neck Cancer) 03/2021 - 08/2005
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2022 - 01/2013
3	Asthma (Bronchial Asthma) 01/2019 - 10/2014
3	Cholesteatoma 08/2018 - 05/2013
3	Wounds and Injuries (Trauma) 01/2018 - 01/2013
3	Hypersensitivity (Allergy) 04/2008 - 05/2006
2	Rheumatoid Arthritis 09/2022 - 01/2013
2	Maxillary Sinus Neoplasms 10/2020 - 11/2019
2	Neoplasm Metastasis (Metastasis) 04/2020 - 05/2015
2	Abscess 01/2020 - 12/2013
2	Airway Obstruction (Choking) 07/2018 - 12/2013
2	Lymphoma (Lymphomas) 11/2017 - 12/2013
2	Middle Ear Cholesteatoma 01/2016 - 05/2013
2	Type 2 Diabetes Mellitus (MODY) 12/2010 - 04/2009
2	Mucocele 03/2007 - 11/2005
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 09/2022
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 12/2020
1	Headache (Headaches) 12/2020
1	Fever (Fevers) 12/2020
1	Colonic Neoplasms (Colon Cancer) 04/2020
1	Lymphangioma (Cavernous Lymphangioma) 01/2020
1	Necrotizing Fasciitis 01/2020
1	Chronic Cough 01/2020

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 04/2019 - 03/2006
10	Immunoglobulin E (IgE)IBA 03/2020 - 01/2004
8	AntigensIBA 03/2020 - 01/2004
7	Messenger RNA (mRNA)IBA 01/2021 - 06/2002
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2005
6	LipopolysaccharidesIBA 01/2020 - 03/2007
6	Macrophage Migration-Inhibitory FactorsIBA 01/2020 - 05/2003
6	Interleukin-5 (Interleukin 5)IBA 01/2016 - 03/2006
5	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 06/2012
5	Prostaglandin D2IBA 01/2021 - 05/2006
5	Immunoglobulin G (IgG)IBA 07/2020 - 01/2004
5	ImmunosorbentsIBA 01/2020 - 03/2007
5	InterleukinsIBA 01/2020 - 03/2006
5	EnzymesIBA 01/2020 - 03/2007
5	Interleukin-10 (Interleukin 10)IBA 07/2018 - 03/2007
5	ProstaglandinsIBA 10/2016 - 05/2006
5	Interleukin-17 (Interleukin 17)IBA 01/2016 - 08/2010
4	Enterotoxins (Enterotoxin)IBA 07/2018 - 04/2009
4	GlucocorticoidsIBA 01/2018 - 06/2015
4	Immunoglobulin A (IgA)IBA 01/2011 - 12/2004
3	Methotrexate (Mexate)FDA LinkGeneric 09/2022 - 01/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 12/2016
3	InflammasomesIBA 01/2020 - 01/2016
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017 - 12/2010
3	SteroidsIBA 01/2017 - 06/2015
3	Interleukin-13IBA 01/2016 - 12/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2013 - 05/2003
3	EndotoxinsIBA 07/2008 - 05/2003
3	Histamine (Histamine Dihydrochloride)FDA Link 06/2007 - 03/2006
2	LigandsIBA 03/2021 - 01/2016
2	Indicators and Reagents (Reagents)IBA 04/2020 - 01/2017
2	ParaffinIBA 04/2020 - 04/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 10/2016
2	Nasal SpraysIBA 01/2019 - 06/2012
2	AllergensIBA 01/2019 - 04/2008
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 03/2006
2	C-Reactive ProteinIBA 11/2014 - 12/2013
2	Hypoglycemic Agents (Hypoglycemics)IBA 12/2010 - 04/2009
2	Insulin (Novolin)FDA Link 12/2010 - 04/2009
2	Prostaglandins DIBA 01/2009 - 04/2008
2	Interleukin-1beta (Interleukin 1 beta)IBA 07/2008 - 05/2003
2	Interleukin-4 (Interleukin 4)IBA 04/2008 - 12/2006
2	Interleukin-12 (IL 12)IBA 03/2007 - 12/2006
1	Histamine Antagonists (Antihistamines)IBA 06/2022
1	Transcription Factors (Transcription Factor)IBA 04/2021
1	Immune Checkpoint ProteinsIBA 03/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	liposomal amphotericin B FDA Link 12/2020
1	Cisplatin (Platino)FDA LinkGeneric 10/2020
1	Biomarkers (Surrogate Marker)IBA 07/2020
1	IgE Receptors (Fc epsilon RI)IBA 03/2020

Therapy/Procedure

10	Therapeutics 12/2020 - 08/2003
6	Hearing Aids (Hearing Aid) 01/2021 - 10/2003
6	Cochlear Implants (Cochlear Implant) 01/2017 - 02/2002
4	Drug Therapy (Chemotherapy) 07/2021 - 03/2006
3	Cochlear Implantation 12/2006 - 02/2002
2	Radiotherapy 10/2020 - 11/2019
2	Tympanoplasty 08/2018 - 05/2005
2	Tonsillectomy 01/2011 - 12/2004
1	Remission Induction 12/2020
1	Mastoidectomy 08/2020